Alpha Teknova Q1 revenue rises, beats estimates

Alpha Teknova, Inc.

Alpha Teknova, Inc.

TKNO

0.00


Overview

  • U.S. reagents producer's Q1 2026 revenue grew 13%, beating analyst expectations

  • Company reaffirmed 2026 revenue guidance of $42-44 mln

  • Gross margin improved to 34.2% from 30.7%, driven by higher revenue


Outlook

  • Alpha Teknova reaffirms 2026 revenue guidance of $42-44 mln

  • Company expects 2026 Free Cash Outflow of less than $10 mln

  • Company says improved market backdrop positions it for above-market growth


Result Drivers

  • CLINICAL SOLUTIONS GROWTH - Clinical Solutions revenue rose 85% year-on-year, supporting overall revenue growth

  • HIGHER SALES AND MARKETING SPEND - Operating expenses increased due to higher sales and marketing costs from increased headcount and marketing activities

  • INVESTMENTS AND MARKET BACKDROP - Management said past investments and an improved market backdrop position the company for above-market growth


Company press release: ID:nGNX7Wr0Rw


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

Beat

$11.08 mln

$10.21 mln (6 Analysts)

Q1 EPS

-$0.08

Q1 Net Income

-$4.56 mln

Q1 Gross Profit

$3.78 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

  • Wall Street's median 12-month price target for Alpha Teknova Inc is $8.00, about 113.9% above its May 5 closing price of $3.74


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.